PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Reginato MJ et al. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. 1998 J. Biol. Chem. pmid:9442016
Horak F et al. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. 1998 Allergy pmid:9491231
Ricote M et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. 1998 Nature pmid:9422508
Jiang C et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. 1998 Nature pmid:9422509
Tan W et al. Modulation of nicotinic AChR channels by prostaglandin E2 in chick sympathetic ganglion neurons. 1998 J. Neurophysiol. pmid:9463448
Nagoshi H et al. Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. 1998 Circ. Res. pmid:9468191
Yang VW et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. 1998 Cancer Res. pmid:9563494
Mooney JJ et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals (coincidence detection). 1998 Biol. Psychiatry pmid:9564442
Souza SC et al. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. 1998 Diabetes pmid:9568706
Tontonoz P et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. 1998 Cell pmid:9568716
Morrow JD et al. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione. 1998 Arch. Biochem. Biophys. pmid:9578611
Wright DH et al. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. 1998 Br. J. Pharmacol. pmid:9579725
Liao CH et al. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets. 1998 Jpn. J. Pharmacol. pmid:9541276
Daculsi R et al. Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes. 1998 Immunol. Lett. pmid:9557948
Chan CL and Lau HY Effects of prostanoid receptor agonists on immunologically-activated rat peritoneal mast cells. 1998 Inflamm. Res. pmid:9561397
Lau HY and Stenton GR Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells. 1998 Inflamm. Res. pmid:9561398
Hwang GS et al. Effects of Brazilin on the phospholipase A2 activity and changes of intracellular free calcium concentration in rat platelets. 1998 Arch. Pharm. Res. pmid:9868555
Sutarmo Setiadji V et al. Actions of prostaglandin E2 on rat supraoptic neurones. 1998 J. Neuroendocrinol. pmid:9870750
Terao A et al. Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. 1998 Neuroreport pmid:9875706
Gambero A and Gomes JC Pharmacological antagonism of Anchietia salutaris extracts on the contraction induced by prostaglandin D2 and U46619 in guinea-pig lung parenchymal strips. 1998 J. Pharm. Pharmacol. pmid:9877316
Gao T et al. Arachidonic acid metabolism to prostaglandin E2, D2, F2alpha, and I2 in the plerocercoid of Spirometra erinaceieuropaei. 1998 J. Parasitol. pmid:9920298
Ohtani-Fujita N et al. p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2. 1998 Biochem. Biophys. Res. Commun. pmid:9792828
Ma H et al. Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue. 1998 J. Biol. Chem. pmid:9804768
Tada K et al. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions. 1998 J. Immunol. pmid:9794438
Tsai WJ et al. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. 1998 Eur. J. Pharmacol. pmid:9617759
Arakida Y et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. 1998 J. Pharmacol. Exp. Ther. pmid:9808690
Nishino S et al. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture. 1998 Psychiatry Res pmid:9657418
Madhu C et al. Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro. 1998 J Ocul Pharmacol Ther pmid:9811228
Thomson AM et al. Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. 1998 Biochem. J. pmid:9657971
Szczeklik A et al. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. 1998 Am. J. Respir. Crit. Care Med. pmid:9769277
Kalgutkar AS et al. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. 1998 Science pmid:9596581
Fiebich BL et al. Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. 1998 J. Neural Transm. Suppl. pmid:9850935
Christman BW Lipid mediator dysregulation in primary pulmonary hypertension. 1998 Chest pmid:9741570
Molderings GJ et al. Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors. 1998 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9826066
Takahashi S et al. Localization of a cyclopentenone prostaglandin to the endoplasmic reticulum and induction of BiP mRNA. 1998 Biochem. J. pmid:9742210
Csala M et al. Prostaglandin-independent stimulation of interleukin-6 production by fibrinogen degradation product D in perfused murine liver. 1998 Scand. J. Immunol. pmid:9743211
Kilunga Kubata B et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. 1998 J. Exp. Med. pmid:9743538
Marx N et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. 1998 Circ. Res. pmid:9831704
Onoe H [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. 1998 Nippon Yakurigaku Zasshi pmid:10202759
Marx N et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. 1998 Am. J. Pathol. pmid:9665460
Seckl J Mechanisms of fetal origins of health problems in adults need to be investigated. 1998 BMJ pmid:9665923
Colville-Nash PR et al. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. 1998 J. Immunol. pmid:9670978
Palea S et al. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. 1998 Br. J. Pharmacol. pmid:9692770
Dorta-Contreras AJ et al. [Beta trace protein in the cerebrospinal fluid and serum in meningoencephalitis]. 1998 Rev Neurol pmid:9585948
Demoly P et al. [Nose and sinus: anatomo-pathologic relations]. 1998 Allerg Immunol (Paris) pmid:9631692
Ikai K et al. Induction of apoptosis, p53 and heme oxygenase-1 by cytotoxic prostaglandin delta12-PGJ2 in transformed endothelial cells. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9654403
Rosenbaum SE and Greenberg AS The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. 1998 Mol. Endocrinol. pmid:9717841
Yoshida T et al. Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. 1998 Surg. Today pmid:9697269
Terao A et al. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. 1998 J. Neurosci. pmid:9698346
Scammell T et al. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9636223
Moon TC et al. Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc epsilon receptor I crosslinking in cultured mast cells. 1998 Cell. Immunol. pmid:9636692
Iijima K et al. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells. 1998 Biochem. Biophys. Res. Commun. pmid:9642130
Fujitani Y et al. [Sleep-promoting substances]. 1998 Nihon Ronen Igakkai Zasshi pmid:10064966
O'Sullivan S et al. Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine. 1998 Thorax pmid:10195076
Longo WE et al. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. 1998 Prostaglandins Other Lipid Mediat. pmid:9990676
Löhrke B et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. 1998 J. Endocrinol. pmid:9834460
Haberl C et al. Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity. 1998 Mediators Inflamm. pmid:9836493
el Attar TM and Virji AS Effects of indomethacin, cisplatin and delta 12-prostaglandin J2 on growth of oral squamous carcinoma cells. 1997 Nov-Dec Anticancer Res. pmid:9494540
Kiriyama M et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. 1997 Br. J. Pharmacol. pmid:9313928
Kanaoka Y et al. Cloning and crystal structure of hematopoietic prostaglandin D synthase. 1997 Cell pmid:9323136
Li Y et al. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. 1997 Prostaglandins pmid:9380795
Fournier T et al. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. 1997 J. Biol. Chem. pmid:9388257
Genovese A et al. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. 1997 Clin. Exp. Allergy pmid:9179431
Murakami M et al. Detection of secretory phospholipase A2s related but not identical to type IIA isozyme in cultured mast cells. 1997 FEBS Lett. pmid:9280291
Harbige LS et al. Cytokine secretion by human T cell clones is differentially regulated by eicosanoids. 1997 Biochem. Soc. Trans. pmid:9191392
Murakami M et al. Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. 1997 J. Immunol. pmid:9200484
ElAttar TM and Virji AS Inhibition of growth in oral squamous carcinoma cells by cyclopentenone prostaglandins: comparison with chemotherapeutic agents. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9223658
Sampson SE et al. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. 1997 Thorax pmid:9227716
Abran D et al. Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs. 1997 Am. J. Physiol. pmid:9087666
Kanamori Y et al. Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans. 1997 Life Sci. pmid:9096262
Ram A et al. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. 1997 Brain Res. pmid:9098570
Ito H et al. Prostaglandins stimulate the stress-induced synthesis of hsp27 and alpha B crystallin. 1997 J. Cell. Physiol. pmid:9066782
Reddy ST et al. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells. 1997 J. Biol. Chem. pmid:9153207
Taber DF et al. A nomenclature system for the isoprostanes. 1997 Prostaglandins pmid:9112285
Minami T et al. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. 1997 Br. J. Pharmacol. pmid:9113374
AL-Hader AA et al. Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains. 1997 Biol. Reprod. pmid:9116153
Bogaards JJ et al. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. 1997 Chem. Res. Toxicol. pmid:9084911
Teixeira MM et al. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. 1997 Br. J. Pharmacol. pmid:9146890
Fiebich BL et al. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. 1997 J. Neurochem. pmid:9003059
Matsumoto H et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. 1997 Biochem. Biophys. Res. Commun. pmid:9020023
Nasushita R et al. A comparative study of adrenocorticotropin-releasing activity of prostaglandins E1, E2, F2 alpha and D2 in the rat. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9051727
Reddy ST and Herschman HR Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. 1997 J. Biol. Chem. pmid:9013559
Urade Y [New aspects on prostaglandin D synthases]. 1997 Nippon Yakurigaku Zasshi pmid:9503406
Boie Y et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. 1997 Eur. J. Pharmacol. pmid:9537820
Minami T et al. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. 1997 Br. J. Pharmacol. pmid:9375954
Mahmud I et al. Prostaglandin D synthase in human megakaryoblastic cells. 1997 J. Biol. Chem. pmid:9353279
Howarth PH Mediators of nasal blockage in allergic rhinitis. 1997 Allergy pmid:9353555
Tsuri T et al. Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: orally active, potent, and selective prostaglandin D2 receptor antagonists. 1997 J. Med. Chem. pmid:9357516
Liakos P et al. ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells. 1997 Am. J. Physiol. pmid:9357777
Werman A et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. 1997 J. Biol. Chem. pmid:9242701
McGowan SE et al. Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. 1997 Am. J. Physiol. pmid:9435581
Blom HM et al. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. 1997 Clin. Exp. Allergy pmid:9249272
Wettstein M and Häussinger D Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. 1997 Hepatology pmid:9397998
Adams M et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. 1997 J. Clin. Invest. pmid:9399962
Ogasawara T et al. Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. 1997 J. Immunol. pmid:8977215
Hutchinson SM et al. Effects of eicosanoids on parameters in isolated rat hepatocytes and isolated rat hepatocyte couplets: protective effects of eicosanoid receptor antagonists. 1997 J Lipid Mediat Cell Signal pmid:9041475
Mezei Z et al. Platelet eicosanoids and the effect of captopril in blood pressure regulation. 1997 Eur. J. Pharmacol. pmid:9527508
Jović N et al. Do prostaglandins E2, F2 alpha and D2 have a role in the development of idiopathic trigeminal neuralgia? 1996 May-Jun Vojnosanit Pregl pmid:9174396
Spannhake EW Down-regulation of canine airway mast cell function following exposure to ozone in vivo. 1996 Mar-Apr Exp. Lung Res. pmid:8706634
O'Sullivan S et al. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. 1996 J. Allergy Clin. Immunol. pmid:8757220